All News

Breast masses are common findings during pregnancy and often difficult to accurately diagnose. That difficulty combined with the false sense of security that a negative ultrasound might impart, can occasionally lull a physician into downplaying what may be a very serious condition.

Questions this month have been answered by:Simon Kipersztok, MD, OBGYN.net Osteoporosis Editorial Advisor Alice Rhoton-Vlasak, MD, OBGYN.net Osteoporosis Editorial AdvisoBarry L. Gruber, MD, OBGYN.net Osteoporosis Editorial Advisor Harvey S.Marchbein, MD, USA, OBGYN.net Osteoporosis Chairman and Editorial Advisor

The possibility that contraceptives are more likely to fail in obese patients is only one reason why you need to take a different tack when counseling them about their most appropriate birth control options. . .

Recently I had the honor to serve as Acting Chair of a Food and Drug Administration (FDA) advisory committee meeting called to provide advice to the Agency on the creation of new guidelines to improve manufacturer-sponsored clinical trials for hormonal contraceptive (HC) agents. . .

No firm relationship exists between folate intake or blood folate levels and breast cancer risk, according to a recent meta-analysis of prospective and case–control studies on the subject, but discrepancy exists in the findings.

It's never too late to quit smoking when it comes to bone density, according to a recent prospective study of postmenopausal women. And it doesn't take long for benefits to begin to accrue.

Women who stop taking alendronate after 5 years do not seem to be at any greater risk for fractures than women who continue treatment, but they do seem to experience a moderate decline in bone mineral density (BMD) and a gradual rise in chemical markers associated with fractures.

Call systems for practicing obstetricians vary widely, with many obstetricians being on call for long hours and most lacking recovery periods after being on call, according to the results of a Wisconsin study published in the January issue of the American Journal of Obstetrics & Gynecology.

Repeating bone mineral density (BMD) scans among postmenopausal women reveals little new information that is helpful in predicting fractures, according to a report in the Jan. 22 issue of the Archives of Internal Medicine.

Children who had nuchal translucency thickening during the first trimester, but a normal karyotype and no structural abnormalities, are clinically and developmentally normal during the first 2 years of life, according to a study in the January issue of the American Journal of Obstetrics & Gynecology.

Good morning. Thank you very much for showing up at this time of morning. I’m astounded at the number of people here, the buzz. It’s terrific. I think Karen emphasized the importance of pelvic floor support.

Q: Is the treatment for Osteoporosis different for males than females? I am a 67 year old male. Recently by x-rays of my back, it was stated in the report that I have osteoporosis . In a phone conversation with my primary physician's assistant, he stated that I should be on hormones, but that he would have to run it by the primary physician. Since that time, and this was at thanksgiving, I have tried to make contact, by phone to the primary physician. I was told, by office personnel, that I should make an appointment to discuss the situation. My question is, why is it necessary to discuss treatment face to face? Can't he advise me by phone? What is necessary? My schedule is very irregular and also why the extra expense for an office visit just to say here is what you do and if a prescription is necessary, can't he call it in as has been done on other occasions. I would like to know also, isn't it rather uncommon for a male to have this condition? Could you tell me what is the usual treatment in this kind of situation?